A first-in-human clinical study to assess safety and tolerability of genetically modified T-cells in ROR1 positive tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512019-36-00

Acronym

LION-1

Enrollment

Registered

2024-07-19

Start date

2025-04-09

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenocortical carcinoma, Breast cancer, Chronic lymphocytic leukemia, Mantle cell lymphoma, Ovarian cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026